Indian drug major Cipla has launched generic versions of anti-flu drugs oseltamivir and zanamivir in the local market to treat the H1N1 influenza, which is spreading across the globe and in
Cipla’s Antiflu is a copycat version of Swiss multi-national Hoffmann-La Roche’s Tamiflu and Virenza is the copy of GlaxoSmithKline’s Relenza. Both drugs, used globally to treat the ongoing H1N1 pandemic, lack patent protection in
The company is equipped to make 2 million doses of oseltamivir a month, in case of any eventuality. Already 450 people have died of H1N1 in
Now the
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1530.00 |
Dr. Reddys Lab | 5913.95 |
Cipla | 1421.00 |
Zydus Lifesciences | 993.40 |
Lupin | 1684.00 |
View more.. |